News

FDA Announces Major Overhaul of COVID-19 Vaccine Strategy
The U.S. Food and Drug Administration (FDA) is changing the game on COVID-19 vaccines. Instead of approving yearly boosters ...
KION54614h
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 ...
The Community Voice15h
FDA Approves Novavax COVID-19 Shot with Restrictions
The FDA has granted full approval for Novavax's COVID-19 vaccine, but with restrictions. Discover the details now.
BofA Reiterates Hold Rating on Novavax (NVAX) Stock
The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from ...
COVID Vaccine Rule Changes Proposed: What To Know In California
A previous federal policy recommended an annual COVID shot for all Americans six months and older. Here is what the new ...
MPR17h
FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access
According to Makary and Prasad, the US’s adoption of a “one-size-fits-all” guidance for COVID-19 vaccination departs from ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
Infectious Disease Advisor19h
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...
FDA’s new approach raises questions about fall COVID vaccine availability
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...